What are you
looking for?

Taking innovations to industrial scale

Siegfried is a leading contract development and manufacturing organization with a global network of 13 production sites on three continents. With 150 years of pharmaceutical and chemical experience, we are taking your innovations to industrial scale.

Our offering

As a globally leading contract development and manufacturing organization, we produce pharmaceutical ingredients and finished products as an integrated supplier.

Bringing together our long-standing pharma and chemical heritage

Learn more

Latest news

See all news
Ad hoc
Media Release Jul 10, 2024
Marcel Imwinkelried appointed as new CEO
Media Release Jul 02, 2024
Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US)
Ad hoc
Media Release Jun 14, 2024
EGS Beteiligungen AG exercises right to convert bond and increases its shareholding in Siegfried to 6.2% registered shares
Ad hoc
Media Release Jun 12, 2024
Siegfried to acquire an early-phase CDMO in Wisconsin (US) to strengthen its Drug Substances service offering
Media Release Apr 18, 2024
Siegfried increases distribution to the shareholders and all proposals of the Board of Directors are approved
Ad hoc
Media Release Apr 02, 2024
Changes in Siegfried’s Management Team
Ad hoc
Media Release Feb 20, 2024
Siegfried continues to deliver profitable growth
Media Release Feb 02, 2024
Changes in Siegfried’s Senior Management Team
Media Release Dec 13, 2023
Siegfried confirmed in the Dow Jones Sustainability Index Europe for the third consecutive year
Ad hoc
Media Release Aug 17, 2023
Siegfried delivers strong sales growth and profitability in first half 2023
Media Release May 15, 2023
Changes in Siegfried’s Executive Committee
Ad hoc
Media Release May 04, 2023
Siegfried acquires majority stake in DINAMIQS to establish a best-in-class development and manufacturing organization for cell and gene therapies
To top